These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6099732)
21. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme]. Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239 [TBL] [Abstract][Full Text] [Related]
22. Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia. Dzau VJ; Hollenberg NK Ann Intern Med; 1984 Jun; 100(6):777-82. PubMed ID: 6372563 [TBL] [Abstract][Full Text] [Related]
23. Long-acting angiotensin-converting enzyme inhibition: once-daily lisinopril versus twice-daily captopril in mild-to-moderate heart failure. Bach R; Zardini P Am J Cardiol; 1992 Oct; 70(10):70C-77C. PubMed ID: 1329477 [TBL] [Abstract][Full Text] [Related]
24. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. Binkley PF; Haas GJ; Starling RC; Nunziata E; Hatton PA; Leier CV; Cody RJ J Am Coll Cardiol; 1993 Mar; 21(3):655-61. PubMed ID: 8436747 [TBL] [Abstract][Full Text] [Related]
25. Captopril versus placebo in congestive heart failure: effects on oxygen delivery to exercising skeletal muscle. Timmis AD; Bojanowski LM; Najm YC; Nelson DJ; Gosling RG Eur Heart J; 1987 Dec; 8(12):1295-304. PubMed ID: 3325289 [TBL] [Abstract][Full Text] [Related]
26. Lisinopril in the treatment of congestive heart failure. Giles TD J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647 [TBL] [Abstract][Full Text] [Related]
27. Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. Cleland JG; Henderson E; McLenachan J; Findlay IN; Dargie HJ J Am Coll Cardiol; 1991 Mar; 17(3):733-9. PubMed ID: 1993795 [TBL] [Abstract][Full Text] [Related]
29. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol. Khattar RS; Senior R; Soman P; van der Does R; Lahiri A Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363 [TBL] [Abstract][Full Text] [Related]
30. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425 [TBL] [Abstract][Full Text] [Related]
31. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure. Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620 [TBL] [Abstract][Full Text] [Related]
32. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril. Turini GA; Waeber B; Brunner HR Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835 [TBL] [Abstract][Full Text] [Related]
33. Acute renal effects of captopril in patients with congestive heart failure. Ribstein J; Mimran A J Clin Hypertens; 1986 Sep; 2(3):238-44. PubMed ID: 3023554 [TBL] [Abstract][Full Text] [Related]
34. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753 [TBL] [Abstract][Full Text] [Related]
35. Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition. Packer M; Medina N; Yushak M Ann Intern Med; 1984 Jun; 100(6):782-9. PubMed ID: 6326629 [TBL] [Abstract][Full Text] [Related]
36. Effect of captopril on renal function in patients with congestive heart failure. Pierpont GL; Francis GS; Cohn JN Br Heart J; 1981 Nov; 46(5):522-7. PubMed ID: 7032555 [TBL] [Abstract][Full Text] [Related]
37. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102 [TBL] [Abstract][Full Text] [Related]
38. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group. J Am Coll Cardiol; 1983 Oct; 2(4):755-63. PubMed ID: 6350401 [TBL] [Abstract][Full Text] [Related]
39. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940 [TBL] [Abstract][Full Text] [Related]
40. Total body and serum electrolyte composition in heart failure: the effects of captopril. Cleland JG; Dargie HJ; East BW; Robertson I; Hodsman GP; Ball SG; Gillen G; Robertson JI; Morton JJ Eur Heart J; 1985 Aug; 6(8):681-8. PubMed ID: 3902475 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]